Related Experiment Video

Updated: Dec 26, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.8K

Mechanical Circulatory Support for Patients With Adult Congenital Heart Disease

Maruti Haranal1, Shuhua Luo1, Osami Honjo1

  • 1Division of Cardiovascular Surgery, The Labatt Family Heart Centre, The Hospital for Sick Children.

Circulation Journal : Official Journal of the Japanese Circulation Society
|March 10, 2020
PubMed

Insights

Adults with congenital heart disease (ACHD) face unique challenges with heart failure (HF). This review explores mechanical circulatory support (MCS) as a vital treatment option for these complex patients.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Mechanical Circulatory Support

Background:

  • Adults with congenital heart disease (ACHD) are a growing population with unique medical needs.
  • Heart failure (HF) is a primary cause of death and illness in ACHD patients.
  • Managing HF in ACHD is complex due to anatomical and physiological variations.

Purpose of the Study:

  • To review clinical experiences with mechanical circulatory support (MCS) in ACHD patients.
  • To highlight the challenges and considerations for MCS in this population.
  • To inform strategies for reducing mortality and morbidity associated with HF in ACHD.

Main Methods:

  • Review of clinical data and experience with MCS devices in ACHD patients.
  • Analysis of the unique anatomical and physiological factors influencing MCS use.
  • Synthesis of current knowledge on optimizing MCS for ACHD.

Main Results:

  • Mechanical circulatory support (MCS) offers an alternative for ACHD patients ineligible for heart transplantation.
  • Unique patient variations necessitate tailored approaches to MCS implantation and management.
  • Clinical experience demonstrates the evolving role of MCS in supporting failing hearts in ACHD.

Conclusions:

  • Mechanical circulatory support (MCS) is an increasingly important therapeutic option for adults with congenital heart disease (ACHD) experiencing heart failure.
  • Further research and tailored strategies are needed to optimize MCS outcomes in this specialized population.
  • Effective management of heart failure in ACHD requires specialized knowledge of mechanical circulatory support devices.

Keywords:
Adult congenital heart diseaseHeart failureMechanical circulatory support

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
193
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297